Status:
COMPLETED
How to Ease the Withdrawal of Tranquilizers Among Older Consumers?
Lead Sponsor:
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Universite du Quebec en Outaouais
Conditions:
Drug Dependence
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Benzodiazepines (BZD) are widely used to treat anxiety, insomnia, and depression. These drugs can have very serious side effects if they are taken over a long period of time. In addition to stability,...
Detailed Description
Benzodiazepines (BZD) represent the most frequently consumed drugs by the elderly persons in Canada. Indeed, there is 7.5 times more BZD users in older people (65 years and over) than in adults (18-64...
Eligibility Criteria
Inclusion
- Be aged 65 years and older;
- To consume benzodiazepine for at least two years (even if consumption is not continuous);
- Want to quit benzodiazepine use.
Exclusion
- Living a difficult situation that requires specific interventions (e.g. bereavement or death, a recent breakup or suicidal thoughts);
- Alcohol or illicit drugs addiction (other than benzodiazepine);
- BZD use for medical reasons (e.g. epilepsy);
- Be unable to complete the questionnaires or to attend meetings for any reason (e.g. Loss of vision, severe arthritis, cognitive impairment, etc.).
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2018
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT02281175
Start Date
August 1 2014
End Date
July 1 2018
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Montreal, Quebec, Canada, H3W 1W5